Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Plan B Backlash Blocks FDA Commissioner Nomination, Take Two

This article was originally published in The Gray Sheet

Executive Summary

FDA will not have a permanent commissioner until a decision is announced on over-the-counter sales of Barr's emergency contraceptive Plan B, if a hold by Senate Democrats is respected

You may also be interested in...



Von Eschenbach Nomination Still Stalled After Some Movement On Plan B

Senators Hilary Rodham Clinton (D-N.Y.) and Patty Murray (D-Wash.) will maintain their hold on Andrew von Eschenbach's nomination to head FDA, despite what von Eschenbach calls an "important decision" regarding Barr Laboratories' application to offer its Plan B emergency contraceptive over the counter (OTC)

Von Eschenbach Nomination Still Stalled After Some Movement On Plan B

Senators Hilary Rodham Clinton (D-N.Y.) and Patty Murray (D-Wash.) will maintain their hold on Andrew von Eschenbach's nomination to head FDA, despite what von Eschenbach calls an "important decision" regarding Barr Laboratories' application to offer its Plan B emergency contraceptive over the counter (OTC)

Von Eschenbach in ‘07?

Senate HELP Committee staffer says it is "highly unlikely" that Acting FDA Commissioner Andrew von Eschenbach, MD, will be confirmed as permanent commissioner this year. The confirmation hold initiated by Sens. Hillary Rodham Clinton (D-N.Y.) and Patty Murray (D-Wash.) stems from political wrangling over the agency's handling of emergency contraceptive drug, Plan B (1"The Gray Sheet" April 3, 2006, p. 13)...

Related Content

UsernamePublicRestriction

Register

MT023399

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel